BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36058860)

  • 1. [Clinical and pathophysiological features of acquired pure red cell aplasia: based on the concept of T-cell dysregulations].
    Ishida F
    Rinsho Ketsueki; 2022; 63(8):893-898. PubMed ID: 36058860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia.
    Kawakami F; Kawakami T; Yamane T; Maruyama M; Kobayashi J; Nishina S; Sakai H; Higuchi Y; Hamanaka K; Hirokawa M; Nakao S; Nakazawa H; Ishida F
    Int J Hematol; 2022 Jun; 115(6):816-825. PubMed ID: 35275353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and management of pure red cell aplasia].
    Fujishima N
    Rinsho Ketsueki; 2021; 62(8):931-937. PubMed ID: 34497233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pure red cell aplasia with thymoma/T-cell large granular lymphocyte leukemia: two cases report and literatures review].
    Zhao X; Zhou K; Ye L; Peng GX; Jing LP; Li Y; Li Y; Fan HH; Song L; Jing LP; Zhang L; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):536-9. PubMed ID: 23827115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent
    Kawakami T; Sekiguchi N; Kobayashi J; Imi T; Matsuda K; Yamane T; Nishina S; Senoo Y; Sakai H; Ito T; Koizumi T; Hirokawa M; Nakao S; Nakazawa H; Ishida F
    Blood Adv; 2018 Oct; 2(20):2704-2712. PubMed ID: 30337298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations in acquired pure red cell aplasia.
    Kawakami T; Nakazawa H; Ishida F
    Semin Hematol; 2022 Jul; 59(3):131-136. PubMed ID: 36115689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress in the diagnosis and management of acquired pure red cell aplasia].
    Ishida F
    Rinsho Ketsueki; 2020; 61(9):1098-1104. PubMed ID: 33162504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia.
    Qiu ZY; Fan L; Wang L; Qiao C; Wu YJ; Zhou JF; Xu W; Li JY
    J Hematol Oncol; 2013 Oct; 6():82. PubMed ID: 24283217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired pure red cell aplasia and T cell large granular lymphocytic leukaemia in patients with autoimmune polyglandular syndrome type 1.
    Ruan J; Wang X; Jiang X; Chen M
    BMC Med Genomics; 2021 Jan; 14(1):22. PubMed ID: 33468135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical characteristics of T cell large granular lymphocyte leukemia associated with pure red cell aplasia].
    Zhou K; Wang HJ; Zhang L; Li HQ; Yang DL; Yan ZS; Jing LP; Wu YH; Chu YL; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):312-5. PubMed ID: 18844068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia.
    Wu X; Cheng L; Liu X; Sun Y; Li B; He G; Li J
    Ann Hematol; 2022 Jul; 101(7):1493-1498. PubMed ID: 35460389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group.
    Hirokawa M; Sawada K; Fujishima N; Teramura M; Bessho M; Dan K; Tsurumi H; Nakao S; Urabe A; Fujisawa S; Yonemura Y; Kawano F; Oshimi K; Sugimoto K; Matsuda A; Karasawa M; Arai A; Komatsu N; Harigae H; Omine M; Ozawa K; Kurokawa M;
    Br J Haematol; 2015 Jun; 169(6):879-86. PubMed ID: 25807974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in the clinical management of pure red cell aplasia and future prospects].
    Hirokawa M
    Rinsho Ketsueki; 2016 Feb; 57(2):110-6. PubMed ID: 26935627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in Japan.
    Nakazawa H; Sakai K; Ohta A; Fujishima N; Matsuda A; Hosokawa K; Nakamura F; Nakao S; Mitani K; Ishida F
    Blood Adv; 2022 Dec; 6(24):6282-6290. PubMed ID: 35522950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure red cell aplasia: The second hundred years.
    Means RT
    Am J Med Sci; 2023 Sep; 366(3):160-166. PubMed ID: 37327996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and management of pure red cell aplasia].
    Hirokawa M
    Rinsho Ketsueki; 2015 Oct; 56(10):1922-31. PubMed ID: 26458430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia.
    Ishida F; Matsuda K; Sekiguchi N; Makishima H; Taira C; Momose K; Nishina S; Senoo N; Sakai H; Ito T; Kwong YL
    Cancer Sci; 2014 Mar; 105(3):342-6. PubMed ID: 24350896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure red cell aplasia with t-cell large granular lymphocytic leukemia.
    Shi G; Hu CM; Yu Q; Yang N; Xue ZS; Zhao B; Guo M; Zheng Y
    J Biol Regul Homeost Agents; 2018; 32(3):589-597. PubMed ID: 29921385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct mutational pattern of T-cell large granular lymphocyte leukemia combined with pure red cell aplasia: low mutational burden of STAT3.
    Park S; Yun J; Choi SY; Jeong D; Gu JY; Lee JS; Seong MW; Chang YH; Yun H; Kim HK
    Sci Rep; 2023 May; 13(1):7280. PubMed ID: 37142644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pure red cell aplasia: Diagnosis, classification and treatment].
    Lobbes H
    Rev Med Interne; 2023 Jan; 44(1):19-26. PubMed ID: 36336519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.